CaraVan Biologix is a biotechnology company that focuses on expanding the life-saving benefits of CAR-T cell therapeutics.
CaraVan Biologix has raised $1.7M in total funding. The most recent round was Seed. The last funding was announced in March 2022.
CaraVan Biologix is headquartered in Andover, United States.
CaraVan Biologix is a biotechnology company that focuses on expanding the life-saving benefits of CAR-T cell therapeutics.
CaraVan Biologix is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CaraVan Biologix — Funding & Investors." VCBacked, March 22, 2022, https://www.vcbacked.co/company/caravan-biologix. Accessed August 17, 2026.
VCBacked. (2022). CaraVan Biologix — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/caravan-biologix
{{cite web |title=CaraVan Biologix — Funding & Investors |url=https://www.vcbacked.co/company/caravan-biologix |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated